Tag Archives: Canada

Drug Pipelines in Canada: Is There a Buyer for Future Innovation?

By Clark Herman | Published: April 15, 2013
Last week, Canada’s National Prescription Drug Utilization Information System (NPDUIS), a federal-provincial fact-finding panel that works closely with the Patented Medicines Prices Review Board (PMPRB), issued its fourth New Drug Pipeline Monitor (NDPM) looking at drugs currently under development that may have an impact on future drug expenditures. The report is another example of how [...]
Posted in Global, IP, Market Access, Orphan Drugs, R&D, Regulatory, healthcare, pricing | Also tagged , , , , | Leave a comment

Are US and Canadian Rx Policies Converging?

By Guest Blogger | Published: March 19, 2013
by Tom Norton As the US pharmaceutical industry anxiously watches the rapid onset of Obamacare, certainly one of the more pressing issues is the debate over the number of drugs that will be reimbursed in each therapeutic class under the Essential Health Benefits (EHB) program.  To say that this is a critical concern for the future [...]
Posted in Global, Guest Blog, Legal, Market Access, Strategy, healthcare | Also tagged , , , , , | Leave a comment

Merck to Close Eight Plants

By Oriana Schwindt | Published: July 8, 2010
Image by Getty Images via @daylife Over the next two years, Merck will shut down eight manufacturing plants, as well as eight research sites, as part of the ongoing Schering-Plough merger process. The company said in a statement that the various site exits will help “create a flexible R&D organization.” Taking a page out of Pfizer’s book [...]
Posted in Strategy | Also tagged , , , , , , | 3 Comments

Pharma Unplugged #2 Layoffs & Bonuses

By George Koroneos | Published: December 7, 2009
Pharma Unplugged #2— Layoffs & Bonuses Recorded: 12/3/2009 Air Date: 12/7/2009 Host: George Koroneos, Pharm Exec Cohost: Reid Paul, Pharm Rep Magazine Show Notes: This week we discuss: Pfizer’s medical education relationship with the Canadian Medical Association Journalists take FDA to task for not being transparent enough Layoffs and job cuts at Sanofi-Aventis New report shows that DTC receives more funding than sales calls in [...]
Posted in News, Podcasts | Also tagged , , , , | Leave a comment

H1N1 Vaccine Quantities to Fall Short of Predictions

By George Koroneos | Published: August 19, 2009
Image by â– Guerry via Flickr The US may not have as many H1N1 flu vaccines available from the get-go as originally anticipated, CBS News reported on Tuesday. According to the report, approximately 45 million doses will be available in mid-October—that’s down from the original plan of 120 million doses. The new plan calls for [...]
Posted in Manufacturing | Also tagged , , , , , | 2 Comments